Document ID: chunk:federal_register_of_legislation:C2007A00099:clause:1_35
Version: federal_register_of_legislation:C2007A00099
Segment Type: clause
Provision Reference: sch 1 cl 35
Character Range: 29455–31192

35  Transitional provision

(1) This item applies if functions are conferred by a corresponding State law upon the Ethics Committee or the Consultative Committee.

(2) Despite the repeals and amendments made by this Part:
 (a) the Ethics Committee and the Consultative Committee that were in existence immediately before the commencement of this item:
 (i) continue in existence after the commencement of this item; and
 (ii) the members of the Ethics and Community Committee are taken to constitute the Ethics Committee and the Consultative Committee, respectively; and
 (b) if, after the commencement of this item, the Ethics and Community Committee performs a function corresponding to a function conferred on the Ethics Committee or the Consultative Committee by a corresponding State law, the Ethics Committee or the Consultative Committee, as continued in existence by this item, is taken to have performed the function.

(3) Despite the repeals and amendments made by this Part, the authority:
 (a) given by section 17 of the Gene Technology Act 2000 (as in force immediately before the commencement of this item); and
 (b) that permits a corresponding State law to confer functions, powers and duties on the Ethics Committee or the Consultative Committee;
continues in effect as if those repeals and amendments had not happened.

(4) In this item:
Consultative Committee has the meaning given by the Gene Technology Act 2000, as in force immediately before the commencement of this item.
Ethics Committee has the meaning given by the Gene Technology Act 2000, as in force immediately before the commencement of this item.

Part 3—Assessment of applications: limited and controlled release and consultation on significant risk